气候变化和健康问责框架:研究正在引领潮流

IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Virginia Barbour
{"title":"气候变化和健康问责框架:研究正在引领潮流","authors":"Virginia Barbour","doi":"10.5694/mja2.52633","DOIUrl":null,"url":null,"abstract":"<p>As I am writing this Editor's Choice, I am in the process of preparing our house in Queensland for a cyclone, predicted to hit Brisbane in about 48 hours. The cover topic of this month's issue of the <i>MJA</i> is therefore very much at the front of my mind.</p><p>This issue contains the seventh report of the <i>MJA–Lancet</i> Countdown on health and climate change, which examines five broad domains: health hazards, exposures and impacts; adaptation, planning and resilience for health; mitigation actions and health co-benefits; economics and finance; and public and political engagement (https://doi.org/10.5694/mja2.52616). The analyses by Beggs and colleagues have some unsurprising but still concerning findings: the exposure to heatwaves in Australia is growing, which in turn increases the risk of heat stress; other health threats such as bushfires and drought — “features of the continent for millennia” — are amplified by climate change. Cyclones, as we are currently facing, are noted as major causes of economic losses. This year, the authors also report against a new indicator: climate litigation over the past decade. The findings are instructive: one case is “a legally significant acceptance, by government, of the science concerning the health impacts of climate change”. However, litigation is just one driver of change. As the authors note: “Nationally, regionally and globally, the next five years are pivotal in reducing greenhouse gas emissions and transitioning energy production to renewables. Australia is now making progress in this direction. This progress must continue and accelerate, and the remaining deficiencies in Australia's response to the health and climate change threat must be addressed”.</p><p>Another perspective in this issue of the <i>MJA</i> discusses the importance of Australia endorsing a fossil fuel non-proliferation treaty (https://doi.org/10.5694/mja2.52610). Colagiuri and colleagues outline the aims of the Fossil Fuel Non-Proliferation Treaty and why it is relevant to health. Starkly put, we are not on track to meet the goals of the Paris Agreement — and as events in the United States unfold, it seems as if political will is shifting even further away from support for the agreement. The authors argue that the Fossil Fuel Non-Proliferation Treaty is a way to directly address the key driver of the climate crisis. It has not been signed by Australia, perhaps unsurprisingly, though eleven Pacific nations, which well understand the risk, have signed on. Endorsing the Fossil Fuel Non-Proliferation Treaty would, the authors argue, be “more than just a climate strategy for Australia; it represents a vital step towards advancing global health justice and fostering regional solidarity”.</p><p>How pharmaceutical companies are progressing in their carbon emission plans is assessed in a research article by Burch and colleagues (https://doi.org/10.5694/mja2.52621). Drawing on publicly available documents on actions during 2015–2023 for the ten largest pharmaceutical companies operating in Australia, they show a very mixed set of results. Some have Science Based Targets initiative (SBTi)-approved targets, monitoring, commitments and evidence of action; others have commitments to SBTi-approved targets but limited publicly disclosed records; and others are without public commitments to achieving net zero emissions, and minimal or no SBTi-approved targets. As the authors conclude, the companies are moving at different rates. Though this is just a snapshot, such monitoring and public documentation are vital for policy makers in supporting change.</p><p>The final article I will highlight touches on a topic — snake bite and its sequelae — that may become more relevant as the climate warms and humans are more exposed to snakes (https://doi.org/10.5694/mja2.52622). In a study spanning 15 years, Isbister and colleagues analyse data from people bitten by snakes, whether they had an early collapse, and the features associated with the collapse. Not surprisingly, they found that early collapse is associated with poorer outcomes. Data on these patients are not easy to collect, but the conclusion that early collapse requires prompt identification and cardiopulmonary resuscitation is a useful clinical finding.</p><p>Increasingly, the association between a changing climate and the effects on human health are becoming clearer and more urgent. If there is one overarching lesson from all these articles, it is that as every year passes, the importance of action becomes even necessary, and the time frame for action is shortening.</p>","PeriodicalId":18214,"journal":{"name":"Medical Journal of Australia","volume":"222 6","pages":"271"},"PeriodicalIF":6.7000,"publicationDate":"2025-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.52633","citationCount":"0","resultStr":"{\"title\":\"Accountability frameworks for climate change and health: research is leading the way\",\"authors\":\"Virginia Barbour\",\"doi\":\"10.5694/mja2.52633\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>As I am writing this Editor's Choice, I am in the process of preparing our house in Queensland for a cyclone, predicted to hit Brisbane in about 48 hours. The cover topic of this month's issue of the <i>MJA</i> is therefore very much at the front of my mind.</p><p>This issue contains the seventh report of the <i>MJA–Lancet</i> Countdown on health and climate change, which examines five broad domains: health hazards, exposures and impacts; adaptation, planning and resilience for health; mitigation actions and health co-benefits; economics and finance; and public and political engagement (https://doi.org/10.5694/mja2.52616). The analyses by Beggs and colleagues have some unsurprising but still concerning findings: the exposure to heatwaves in Australia is growing, which in turn increases the risk of heat stress; other health threats such as bushfires and drought — “features of the continent for millennia” — are amplified by climate change. Cyclones, as we are currently facing, are noted as major causes of economic losses. This year, the authors also report against a new indicator: climate litigation over the past decade. The findings are instructive: one case is “a legally significant acceptance, by government, of the science concerning the health impacts of climate change”. However, litigation is just one driver of change. As the authors note: “Nationally, regionally and globally, the next five years are pivotal in reducing greenhouse gas emissions and transitioning energy production to renewables. Australia is now making progress in this direction. This progress must continue and accelerate, and the remaining deficiencies in Australia's response to the health and climate change threat must be addressed”.</p><p>Another perspective in this issue of the <i>MJA</i> discusses the importance of Australia endorsing a fossil fuel non-proliferation treaty (https://doi.org/10.5694/mja2.52610). Colagiuri and colleagues outline the aims of the Fossil Fuel Non-Proliferation Treaty and why it is relevant to health. Starkly put, we are not on track to meet the goals of the Paris Agreement — and as events in the United States unfold, it seems as if political will is shifting even further away from support for the agreement. The authors argue that the Fossil Fuel Non-Proliferation Treaty is a way to directly address the key driver of the climate crisis. It has not been signed by Australia, perhaps unsurprisingly, though eleven Pacific nations, which well understand the risk, have signed on. Endorsing the Fossil Fuel Non-Proliferation Treaty would, the authors argue, be “more than just a climate strategy for Australia; it represents a vital step towards advancing global health justice and fostering regional solidarity”.</p><p>How pharmaceutical companies are progressing in their carbon emission plans is assessed in a research article by Burch and colleagues (https://doi.org/10.5694/mja2.52621). Drawing on publicly available documents on actions during 2015–2023 for the ten largest pharmaceutical companies operating in Australia, they show a very mixed set of results. Some have Science Based Targets initiative (SBTi)-approved targets, monitoring, commitments and evidence of action; others have commitments to SBTi-approved targets but limited publicly disclosed records; and others are without public commitments to achieving net zero emissions, and minimal or no SBTi-approved targets. As the authors conclude, the companies are moving at different rates. Though this is just a snapshot, such monitoring and public documentation are vital for policy makers in supporting change.</p><p>The final article I will highlight touches on a topic — snake bite and its sequelae — that may become more relevant as the climate warms and humans are more exposed to snakes (https://doi.org/10.5694/mja2.52622). In a study spanning 15 years, Isbister and colleagues analyse data from people bitten by snakes, whether they had an early collapse, and the features associated with the collapse. Not surprisingly, they found that early collapse is associated with poorer outcomes. Data on these patients are not easy to collect, but the conclusion that early collapse requires prompt identification and cardiopulmonary resuscitation is a useful clinical finding.</p><p>Increasingly, the association between a changing climate and the effects on human health are becoming clearer and more urgent. If there is one overarching lesson from all these articles, it is that as every year passes, the importance of action becomes even necessary, and the time frame for action is shortening.</p>\",\"PeriodicalId\":18214,\"journal\":{\"name\":\"Medical Journal of Australia\",\"volume\":\"222 6\",\"pages\":\"271\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2025-04-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.52633\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Journal of Australia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.5694/mja2.52633\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Australia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.5694/mja2.52633","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

当我写这篇《编辑选择》时,我正在为我们在昆士兰的家做准备,以应对一场飓风,预计将在48小时后袭击布里斯班。因此,这个月MJA杂志的封面主题是我最关心的。本期载有《柳叶刀》健康与气候变化倒计时第七次报告,该报告审查了五个广泛领域:健康危害、暴露和影响;健康适应、规划和复原力;缓解行动和健康惠益;经济金融;公众和政治参与(https://doi.org/10.5694/mja2.52616)。贝格斯及其同事的分析得出了一些不足为奇但仍令人担忧的发现:澳大利亚的热浪暴露正在增加,这反过来又增加了热应激的风险;其他健康威胁,如森林大火和干旱——“这片大陆几千年来的特征”——被气候变化放大了。我们目前面临的飓风是造成经济损失的主要原因。今年,作者们还报告了一个新的指标:过去十年的气候诉讼。调查结果很有启发性:其中一个案例是“政府在法律上重大地接受了有关气候变化对健康影响的科学研究”。然而,诉讼只是推动变革的一个因素。正如作者所指出的那样:“在国家、地区和全球范围内,未来五年是减少温室气体排放和向可再生能源生产过渡的关键。澳大利亚现在正朝着这个方向取得进展。必须继续并加速这一进展,必须解决澳大利亚在应对健康和气候变化威胁方面仍存在的不足"。MJA这一问题的另一个观点讨论了澳大利亚赞同一项不扩散化石燃料条约的重要性(https://doi.org/10.5694/mja2.52610)。Colagiuri及其同事概述了《不扩散化石燃料条约》的目标及其与健康相关的原因。坦率地说,我们没有走上实现《巴黎协定》目标的轨道——随着美国事态的发展,似乎政治意愿正在进一步背离对该协定的支持。这组作者认为,《不扩散化石燃料条约》是直接解决气候危机关键驱动因素的一种方式。澳大利亚没有签署,这也许并不令人意外,尽管11个深知风险的太平洋国家已经签署了协议。作者认为,支持《不扩散化石燃料条约》将“不仅仅是澳大利亚的一项气候战略;这是朝着促进全球卫生正义和促进区域团结迈出的重要一步”。Burch及其同事的一篇研究文章评估了制药公司在碳排放计划方面的进展情况(https://doi.org/10.5694/mja2.52621)。根据2015-2023年在澳大利亚运营的十大制药公司的公开行动文件,他们展示了一组非常复杂的结果。有些国家有科学目标倡议(SBTi)批准的目标、监测、承诺和行动证据;其他公司承诺实现sbti批准的目标,但公开披露的记录有限;而其他国家则没有公开承诺实现净零排放,并且很少或没有sbti批准的目标。正如作者总结的那样,这些公司正在以不同的速度发展。虽然这只是一个快照,但这种监测和公共文件对于政策制定者支持变革至关重要。最后一篇文章我将重点关注一个话题——蛇咬伤及其后遗症——随着气候变暖,人类更容易接触蛇,这个话题可能会变得更加相关(https://doi.org/10.5694/mja2.52622)。在一项长达15年的研究中,Isbister和他的同事分析了被蛇咬伤的人的数据,他们是否有早期的崩溃,以及与崩溃相关的特征。毫不奇怪,他们发现早期崩溃与较差的结果有关。这些患者的数据不容易收集,但早期崩溃需要及时识别和心肺复苏的结论是一个有用的临床发现。气候变化与对人类健康的影响之间的联系日益清晰和紧迫。如果从所有这些文章中得到一个最重要的教训,那就是随着时间的流逝,行动的重要性变得更加必要,而采取行动的时间框架正在缩短。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Accountability frameworks for climate change and health: research is leading the way

As I am writing this Editor's Choice, I am in the process of preparing our house in Queensland for a cyclone, predicted to hit Brisbane in about 48 hours. The cover topic of this month's issue of the MJA is therefore very much at the front of my mind.

This issue contains the seventh report of the MJA–Lancet Countdown on health and climate change, which examines five broad domains: health hazards, exposures and impacts; adaptation, planning and resilience for health; mitigation actions and health co-benefits; economics and finance; and public and political engagement (https://doi.org/10.5694/mja2.52616). The analyses by Beggs and colleagues have some unsurprising but still concerning findings: the exposure to heatwaves in Australia is growing, which in turn increases the risk of heat stress; other health threats such as bushfires and drought — “features of the continent for millennia” — are amplified by climate change. Cyclones, as we are currently facing, are noted as major causes of economic losses. This year, the authors also report against a new indicator: climate litigation over the past decade. The findings are instructive: one case is “a legally significant acceptance, by government, of the science concerning the health impacts of climate change”. However, litigation is just one driver of change. As the authors note: “Nationally, regionally and globally, the next five years are pivotal in reducing greenhouse gas emissions and transitioning energy production to renewables. Australia is now making progress in this direction. This progress must continue and accelerate, and the remaining deficiencies in Australia's response to the health and climate change threat must be addressed”.

Another perspective in this issue of the MJA discusses the importance of Australia endorsing a fossil fuel non-proliferation treaty (https://doi.org/10.5694/mja2.52610). Colagiuri and colleagues outline the aims of the Fossil Fuel Non-Proliferation Treaty and why it is relevant to health. Starkly put, we are not on track to meet the goals of the Paris Agreement — and as events in the United States unfold, it seems as if political will is shifting even further away from support for the agreement. The authors argue that the Fossil Fuel Non-Proliferation Treaty is a way to directly address the key driver of the climate crisis. It has not been signed by Australia, perhaps unsurprisingly, though eleven Pacific nations, which well understand the risk, have signed on. Endorsing the Fossil Fuel Non-Proliferation Treaty would, the authors argue, be “more than just a climate strategy for Australia; it represents a vital step towards advancing global health justice and fostering regional solidarity”.

How pharmaceutical companies are progressing in their carbon emission plans is assessed in a research article by Burch and colleagues (https://doi.org/10.5694/mja2.52621). Drawing on publicly available documents on actions during 2015–2023 for the ten largest pharmaceutical companies operating in Australia, they show a very mixed set of results. Some have Science Based Targets initiative (SBTi)-approved targets, monitoring, commitments and evidence of action; others have commitments to SBTi-approved targets but limited publicly disclosed records; and others are without public commitments to achieving net zero emissions, and minimal or no SBTi-approved targets. As the authors conclude, the companies are moving at different rates. Though this is just a snapshot, such monitoring and public documentation are vital for policy makers in supporting change.

The final article I will highlight touches on a topic — snake bite and its sequelae — that may become more relevant as the climate warms and humans are more exposed to snakes (https://doi.org/10.5694/mja2.52622). In a study spanning 15 years, Isbister and colleagues analyse data from people bitten by snakes, whether they had an early collapse, and the features associated with the collapse. Not surprisingly, they found that early collapse is associated with poorer outcomes. Data on these patients are not easy to collect, but the conclusion that early collapse requires prompt identification and cardiopulmonary resuscitation is a useful clinical finding.

Increasingly, the association between a changing climate and the effects on human health are becoming clearer and more urgent. If there is one overarching lesson from all these articles, it is that as every year passes, the importance of action becomes even necessary, and the time frame for action is shortening.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medical Journal of Australia
Medical Journal of Australia 医学-医学:内科
CiteScore
9.40
自引率
5.30%
发文量
410
审稿时长
3-8 weeks
期刊介绍: The Medical Journal of Australia (MJA) stands as Australia's foremost general medical journal, leading the dissemination of high-quality research and commentary to shape health policy and influence medical practices within the country. Under the leadership of Professor Virginia Barbour, the expert editorial team at MJA is dedicated to providing authors with a constructive and collaborative peer-review and publication process. Established in 1914, the MJA has evolved into a modern journal that upholds its founding values, maintaining a commitment to supporting the medical profession by delivering high-quality and pertinent information essential to medical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信